Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1184302.RAfy4v7nbj4PPEM0kvSKAhR9xh1EhI-TOWbS7f-ivfFHA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1184302.RAfy4v7nbj4PPEM0kvSKAhR9xh1EhI-TOWbS7f-ivfFHA130_assertion type Assertion NP1184302.RAfy4v7nbj4PPEM0kvSKAhR9xh1EhI-TOWbS7f-ivfFHA130_head.
- NP1184302.RAfy4v7nbj4PPEM0kvSKAhR9xh1EhI-TOWbS7f-ivfFHA130_assertion wasGeneratedBy ECO_0000203 NP1184302.RAfy4v7nbj4PPEM0kvSKAhR9xh1EhI-TOWbS7f-ivfFHA130_provenance.
- NP1184302.RAfy4v7nbj4PPEM0kvSKAhR9xh1EhI-TOWbS7f-ivfFHA130_assertion wasDerivedFrom befree-2016 NP1184302.RAfy4v7nbj4PPEM0kvSKAhR9xh1EhI-TOWbS7f-ivfFHA130_provenance.
- NP1184302.RAfy4v7nbj4PPEM0kvSKAhR9xh1EhI-TOWbS7f-ivfFHA130_assertion SIO_000772 24847764 NP1184302.RAfy4v7nbj4PPEM0kvSKAhR9xh1EhI-TOWbS7f-ivfFHA130_provenance.
- NP1184302.RAfy4v7nbj4PPEM0kvSKAhR9xh1EhI-TOWbS7f-ivfFHA130_assertion evidence source_evidence_literature NP1184302.RAfy4v7nbj4PPEM0kvSKAhR9xh1EhI-TOWbS7f-ivfFHA130_provenance.
- NP1184302.RAfy4v7nbj4PPEM0kvSKAhR9xh1EhI-TOWbS7f-ivfFHA130_assertion description "[A phase I clinical trial of the Ad/PSA vaccine in men with metastatic castrate-resistant prostate cancer demonstrated the safety of the vaccine even at the highest single dose permitted by the FDA.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1184302.RAfy4v7nbj4PPEM0kvSKAhR9xh1EhI-TOWbS7f-ivfFHA130_provenance.